+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Progesterone"

Oral Contraceptive Pills Market Report 2025 - Product Thumbnail Image

Oral Contraceptive Pills Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Gynecology Drugs Market Report 2025 - Product Thumbnail Image

Gynecology Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Uterine Fibroids Treatment Market Report 2025 - Product Thumbnail Image

Uterine Fibroids Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Contraceptives Market Report 2025 - Product Thumbnail Image

Contraceptives Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Emergency Contraceptive Pills Market 2024-2028 - Product Thumbnail Image

Emergency Contraceptive Pills Market 2024-2028

  • Report
  • May 2024
  • 162 Pages
  • Global
From
From
From
Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Triple Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Triple Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Dysmenorrhea - Pipeline Insight, 2024 - Product Thumbnail Image

Dysmenorrhea - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Uterine fibroids - Pipeline Insight, 2024 - Product Thumbnail Image

Uterine fibroids - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Uterine Fibroids Pipeline Analysis Report - Product Thumbnail Image

Uterine Fibroids Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
Hormone Replacement Therapy Market Overview, 2024-2029 - Product Thumbnail Image

Hormone Replacement Therapy Market Overview, 2024-2029

  • Report
  • April 2024
  • 105 Pages
  • Global
From
Hormone Replacement Therapy Market Outlook, 2029 - Product Thumbnail Image

Hormone Replacement Therapy Market Outlook, 2029

  • Report
  • April 2024
  • 192 Pages
  • Global
From
Middle East & Africa Hormone Replacement Therapy Market Outlook, 2029 - Product Thumbnail Image

Middle East & Africa Hormone Replacement Therapy Market Outlook, 2029

  • Report
  • April 2024
  • 81 Pages
  • Middle East, Africa
From
Loading Indicator

Progesterone is a hormone that plays an important role in women's health. It is produced by the ovaries and is essential for the regulation of the menstrual cycle, fertility, and pregnancy. Progesterone is also used to treat a variety of conditions, including abnormal uterine bleeding, endometriosis, and premenstrual syndrome. It is available in a variety of forms, including oral tablets, topical creams, and injections. The progesterone market is an important part of the women's health industry. It is driven by the increasing prevalence of conditions such as endometriosis and premenstrual syndrome, as well as the growing demand for hormone replacement therapy. The market is also influenced by the availability of new products and technologies, such as transdermal patches and vaginal rings. Some companies in the progesterone market include Pfizer, Merck, AbbVie, and Novo Nordisk. Show Less Read more